Further research is necessary to confirm these results in vivo and to clarify whether NK cell activating receptors other than NKG2D, such as NCRs, may play a similar role, being responsible for DNAM-1 hypo-functionality in the tumor microenvironment. This evidence concerns the gene CD226 and neoplasm.